cjc no dac + ipamorelin CJC-1295 (NO DAC) – Research Peptide CJC-1295 Ipamorelin Blend Peptide |

The patients were followed up for a period of 3 months

However, growth hormone peptides like ipamorelin and tesamorelin operate through different neuroendocrine axes than GLP-1 mechanisms

Key Takeaways CJC-1295 plus Ipamorelin is not FDA approved: There is no approved CJC-1295/Ipamorelin brand, finished drug, or human therapeutic indication

While the mechanism makes sense and initial reports are encouraging, more research is needed before it can be confidently recommended as an anti-aging skin therapy

However, if these side effects persist or become severe, patients should contact their healthcare provider for further evaluation and guidance